bioMerieux consumables (strips, API, cards) for VITEK and VIDAS instruments

The U.S. Food and Drug Administration’s Office of Acquisitions and Grants Services is conducting market research through a Sources Sought Notice to identify capable vendors for a potential five-year Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract to supply proprietary bioMerieux consumables for VIDAS and VITEK automated microbiology systems. The required products include API 20 E and Listeria strips, SX2 Broth tubes, VITEK 2 identification cards, and VITEK MS slides and reagents, all of which must meet exact technical specifications and be fully compatible with FDA’s laboratory instrumentation. All items must be individually foil-sealed, include barcode labeling with assay code, lot number, and expiration date, and maintain a minimum shelf life of six months from the date of delivery. Lot consistency is mandatory across all shipments, and products must be manufactured in the United States or, if not, require a formal Buy American Act waiver submission via the MIAO Digital Waiver Portal. Responses must be submitted via email to timothy.walbert@fda.hhs.gov by 2:00 PM Central Daylight Time on May 15, 2026, and must include the respondent’s SAM Unique Entity ID, business size status, manufacturing location, past performance, and detailed evidence of capability without reliance on web links or unsubstantiated claims. The anticipated contract period begins June 1, 2026, with four option years extending through May 31, 2031, and deliveries are required F.O.B. Destination to multiple FDA laboratory sites across the contiguous United States. No formal contract clauses, evaluation factors, pricing estimates, or payment details are included, as this is a pre-solicitation market research action aimed at assessing vendor readiness and product availability rather than initiating a procurement.